Linus S.

Hays, KS

Age: 64 | Location: Hays, KS | Condition: COPD

Linus works in construction and restoration, a physically demanding occupation. When he began having trouble climbing stairs on work sites and decided to look into COPD treatment options, 4 family members—who happened to be nurses—suggested he look into stem cell therapy. They also recommended he contact the Lung Institute.

Less than 3 months after his venous treatment in July of 2015, Linus noticed he no longer had to pause to recover while working. At the top of a 26-stair climb he noticed that he was breathing easier than he had been before. “I noticed one day that when I got to the top, I didn’t have to stop, and didn’t have to use my inhaler.”

If you or a loved one has COPD or any other form of lung disease, and would like to see results like Linus, please contact one of our patient coordinators or call us at (800) 729-3065.

Jerry E.
Kernersville, NC
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Thomas V.
Keene, NH
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Tammi S.
Cleveland, OH
Albert C.
Trumansburg, NY
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Sherry B.
Nashville, TN
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Peter P.
Cape Coral, FL
Michael F.
Georgetown, TX
Susan B.
Edison, NJ
Lois S.
Sun City, AZ
Wayne H.
Houston, TX
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Harold T.
Birmingham, AL
Mike K.
Leesburg, FL
Jim D.
Boca Raton, FL
Jean H.
Houston, TX
Ike M.
Enterprise, MS
Marvin S.
Lakeland, FL
Edmond O.
Vermillion, SD

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.